Succinylcholine Injectable Syringes Recalled for Sterility Validation Deficiency
Central Admixture Pharmacy Services Inc recalls 12,239 succinylcholine injection syringes (200 mg/10 mL) distributed nationwide due to lack of validation data for sanitization cycles.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable pharmaceutical with sterility assurance deficiency and no reported illnesses or injuries. The hazard qualifies as a risk-of-harm product where injury has not yet been reported, meeting the High severity criterion.
Plain-English summary
Central Admixture Pharmacy Services Inc is recalling 12,239 syringes of succinylcholine 200 mg/10 mL (20 mg/mL concentration) distributed nationwide in the United States. Succinylcholine is an injectable medication administered during surgical anesthesia.
The recall was initiated because validation data for sanitization cycles are lacking, meaning the manufacturer cannot verify that their sterilization processes are adequate to ensure product sterility. This raises potential concerns about bacterial or fungal contamination in the affected lots.
The affected product includes multiple lot numbers (17-270532, 17-270538, 17-270601, 17-270888, 17-271680, 17-271828, 17-271959, 17-272232, 17-272239, 17-272338, 17-272452, 17-272463, 17-272551, 17-272557, 17-272800, 17-272819, 17-272889, 17-272917, 17-272978, 17-273077, 17-273166, 17-273604, 17-273729, 17-273731, 17-273854, and 17-273870) with expiration dates ranging from July 2023 through September 2023. All affected units were distributed nationwide.
Healthcare facilities and anesthesia practitioners who have received these syringes should immediately discontinue use of the affected lots and quarantine the product. Contact Central Admixture Pharmacy Services Inc regarding return or destruction. Report any adverse events to the FDA.
The recalled product
- Product
- succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6011-2
- Manufacturer
- Central Admixture Pharmacy Services Inc
- Category
- Drug — Injectable Anesthesia
- Affected units
- 12,239
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot: 17-270532
- 17-270538
- Exp
- 7/16/2023
- 17-270601
- 7/17/2023
- 17-270888
- 7/20/2023
- 17-271680
- 8/2/2023
- 17-271828
- 8/6/2023
- 17-271959
- 8/8/2023
- 17-272232
- 17-272239
- 8/13/2023
- 17-272338
- 8/15/2023
- 17-272452
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 39 recalled by Central Admixture Pharmacy Services Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 39 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services Inc
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighEphedrine Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighFentanyl injectable syringes recalled nationwide for sterility assurance failure
FDA (Drugs) · 2023-10-11
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- HighInjectable Succinylcholine Syringes Recalled for Sterility Assurance Failure
FDA (Drugs) · 2023-10-11
- HighSuccinylcholine Injectable Syringes Recalled for Unvalidated Decontamination Cycles
FDA (Drugs) · 2023-08-09
- HighSuccinylcholine Chloride Injection Recalled for Sterility Assurance Failure
FDA (Drugs) · 2024-04-03
- HighSuccinylcholine chloride injection recalled for lack of sterility assurance
FDA (Drugs) · 2024-04-03
- SevereSuccinylcholine Chloride Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-08-11
- SevereSCA Pharmaceuticals Recalls Succinylcholine Chloride Syringes Due to Sterility Concerns
FDA (Drugs) · 2021-01-13